North America Cell Therapy Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Therapy Type (Allogeneic and Autologous), Product (Consumables, Equipment, and Systems and Software), Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, and Three-Dimensional Technology), Application (Oncology, Cardiovascular, Orthopedic, Wound Management, and Other Applications), and End User (Research Institutes, Hospitals, and Others), and Country

No. of Pages: 158
Report Code: TIPRE00018850
Category: Life Sciences
North America Cell Therapy Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Cell Therapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Cell Therapy Market Regional Analysis

6.2 North America Cell Therapy Market Revenue 2017-2027 (US$ Million)
6.3 North America Cell Therapy Market Forecast Analysis

7. North America Cell Therapy Market Analysis – by Therapy Type

7.1 Allogeneic and Autologous
  • 7.1.1 Overview
  • 7.1.2 Allogeneic and Autologous: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Cell Therapy Market Analysis – by Product

8.1 Consumables
  • 8.1.1 Overview
  • 8.1.2 Consumables: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Equipment
  • 8.2.1 Overview
  • 8.2.2 Equipment: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Systems and Software
  • 8.3.1 Overview
  • 8.3.2 Systems and Software: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Cell Therapy Market Analysis – by Technology

9.1 Viral Vector Technology
  • 9.1.1 Overview
  • 9.1.2 Viral Vector Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Genome Editing Technology
  • 9.2.1 Overview
  • 9.2.2 Genome Editing Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Somatic Cell Technology
  • 9.3.1 Overview
  • 9.3.2 Somatic Cell Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Cell Immortalization Technology
  • 9.4.1 Overview
  • 9.4.2 Cell Immortalization Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Cell Plasticity Technology
  • 9.5.1 Overview
  • 9.5.2 Cell Plasticity Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.6 Three-Dimensional Technology
  • 9.6.1 Overview
  • 9.6.2 Three-Dimensional Technology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Cell Therapy Market Analysis – by Application

10.1 Oncology
  • 10.1.1 Overview
  • 10.1.2 Oncology: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Cardiovascular
  • 10.2.1 Overview
  • 10.2.2 Cardiovascular: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Orthopedic
  • 10.3.1 Overview
  • 10.3.2 Orthopedic: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.4 Wound Management
  • 10.4.1 Overview
  • 10.4.2 Wound Management: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.5 Other Applications
  • 10.5.1 Overview
  • 10.5.2 Other Applications: North America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. North America Cell Therapy Market – North America Analysis

11.1 Overview

11.2 North America
  • 11.2.1 North America Cell Therapy Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 11.2.1.1 North America Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 US: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.1.1 US: North America Cell Therapy Market Breakdown, by Therapy Type
    • 11.2.1.1.2 US: North America Cell Therapy Market Breakdown, by Product
    • 11.2.1.1.3 US: North America Cell Therapy Market Breakdown, by Technology
    • 11.2.1.1.4 US: North America Cell Therapy Market Breakdown, by Application
  • 11.2.1.2 Canada: North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.2.1 Canada: North America Cell Therapy Market Breakdown, by Therapy Type
    • 11.2.1.2.2 Canada: North America Cell Therapy Market Breakdown, by Product
    • 11.2.1.2.3 Canada: North America Cell Therapy Market Breakdown, by Technology
    • 11.2.1.2.4 Canada: North America Cell Therapy Market Breakdown, by Application
  • 11.2.1.3 Mexico : North America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.3.1 Mexico : North America Cell Therapy Market Breakdown, by Therapy Type
    • 11.2.1.3.2 Mexico : North America Cell Therapy Market Breakdown, by Product
    • 11.2.1.3.3 Mexico : North America Cell Therapy Market Breakdown, by Technology
    • 11.2.1.3.4 Mexico : North America Cell Therapy Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Vericel Corporation
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 MEDIPOST
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 NuVasive, Inc
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Mesoblast Limited
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Smith & Nephew
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Stemedica Cell Technologies, Inc
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Castle Creek Biosciences, Inc.
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - North America Cell Therapy Market

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)